Institutional Ownership
Bridgebio Oncology Therapeut
CUSIP 107924102COM NEWBBOTQ1 2026
13D / 13G Filings
7
Schedule 13D/13G on record
Beneficial Filers
7
Distinct reporting persons
Largest Stake
22.6%
Max % of class reported
Institutional Holders
63
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
7 filings · latest Nov 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 14, 2025 | Citadel Advisors LLC | 13G/A | 3.2% | 2.54M | SEC |
| 2 | Nov 14, 2025 | T. Rowe Price Associates, Inc. | 13G | 1.1% | 885.0K | SEC |
| 3 | Nov 13, 2025 | Adage Capital Management, L.P. | 13G/A | 1.9% | 1.49M | SEC |
| 4 | Sep 3, 2025 | Bc Global Opportunities Ix LP | 13G | 5.5% | — | SEC |
| 5 | Aug 18, 2025 | Deerfield Mgmt, L.P. | 13G | 6.2% | 4.89M | SEC |
| 6 | Aug 18, 2025 | Bridgebio Pharma LLC | 13D | 17.5% | — | SEC |
| 7 | Aug 13, 2025 | Helix Holdings II LLC | 13D/A | 22.6% | — | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Cormorant Asset Management, LP | 17.88M | $160.01M |
| 2 | Deerfield Management Company, L.P. | 4.89M | $43.72M |
| 3 | Omega Fund Management, LLC | 3.29M | $29.44M |
| 4 | Ecor1 Capital, LLC | 2.82M | $25.27M |
| 5 | Alphabet Inc. | 2.82M | $25.27M |
| 6 | Wellington Management Group LLP | 2.82M | $25.22M |
| 7 | Enavate Sciences Gp, LLC | 2.63M | $23.51M |
| 8 | Citadel Advisors LLC | 2.53M | $22.63M |
| 9 | Novo Holdings A/S | 2.19M | $19.56M |
| 10 | Blackrock, Inc. | 2.09M | $18.69M |